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Human monogenic obesity syndromes, including
Bardet-Biedl syndrome (BBS), implicate neuronal
primary cilia in regulation of energy homeostasis.
Cilia in hypothalamic neurons have been hypothe-
sized to sense and regulate systemic energy status,
but the molecular mechanism of this signaling
remains unknown. Here, we report a comprehensive
localization screen of 42 G-protein-coupled recep-
tors (GPCR) revealing seven ciliary GPCRs, including
the neuropeptide Y (NPY) receptors NPY2R and
NPY5R. We show that mice modeling BBS disease
or obese tubby mice fail to localize NPY2R to cilia
in the hypothalamus and that BBS mutant mice fail
to activate c-fos or decrease food intake in response
to the NPY2R ligand PYY3-36. We find that cells with
ciliary NPY2R show augmented PYY3-36-dependent
cAMP signaling. Our data demonstrate that ciliary
targeting of NPY receptors is important for control-
ling energy balance in mammals, revealing a physio-
logically defined ligand-receptor pathway signaling
within neuronal cilia.
INTRODUCTION
The primary cilium has recently emerged as a cellular organelle
important in many signaling cascades, including the Sonic
hedgehog pathway and G-protein-coupled receptors (GPCR)
signaling. In mammals, primary cilia appear to play an especially
important role in the development,morphogenesis, and signaling
in the brain (Lee and Gleeson, 2011). This is highlighted by rare
human genetic diseases involving primary cilia (ciliopathies)
that have a wide spectrum of neurological features. One of the
more severe ciliopathies—Meckel-Gruber syndrome—presents
with perinatal lethality due to severe brain malformations (Lee
and Gleeson, 2011). In milder ciliopathies, such as Bardet-Biedl
syndrome (BBS) and Alstrom syndrome, patients manifest hy-1316 Cell Reports 5, 1316–1329, December 12, 2013 ª2013 The Autperphagia and truncal obesity, among other developmental,
degenerative, and metabolic symptoms (Sheffield, 2010). These
rare human genetic diseases are notable for their potential to
reveal general mechanisms for how neuronal primary cilia influ-
ence neuronal signaling to regulate energy homeostasis.
In the brain, the hypothalamus has been traditionally consid-
ered a master regulator of energy homeostasis. Ciliated first-
order neurons in the arcuate nucleus (ACN) of the hypothalamus
receive and integrate inputs from a number of peripheral orexi-
genic and anorexigenic signals to regulate food intake and en-
ergy expenditure. Notably, two integrated subpopulations of
ACN neurons specified by their expression of neuropeptide Y
(NPY) or pro-opiomelanocortin (POMC) neuropeptides exert
opposing action on food intake. The NPY neurons stimulate
feeding, whereas POMC neurons inhibit (Nguyen et al., 2011).
Several lines of evidence suggest a crucial role of cilia in hypo-
thalamic ACN neurons for their function and consequently en-
ergy homeostasis. Ablation of primary cilia throughout the brain
in adult mice with conditional knockout of intraflagellar transport
(IFT) proteins results in the development of hyperphagia and
obesity. Mice with the same IFT knockout specifically in
POMC neurons are similarly obese and hyperphagic (Davenport
et al., 2007). Obese mice mutant in the Alstrom syndrome gene
ALMS1 progressively lose hypothalamic cilia during develop-
ment (Heydet et al., 2013). Whereas IFT mutant mice lack cilia
entirely, multiple mouse models of BBS have relatively structur-
ally intact cilia in the brain but develop hyperphagia-driven
obesity similarly to IFT mutants, with the hypothesis being that
BBS defects lead to signaling, rather than architectural, defects
in cilia. A central question is to identify and understand the spe-
cific BBS-dependent ciliary signaling pathways important for
this metabolic deficiency.
A small set of GPCRs, namely, serotonin receptor 6 (5HT6),
somatostatin receptor 3 (SSTR3), and melanin-concentrating
hormone receptor 1 (MCHR1) have been shown to be highly
enriched in neuronal cilia (Berbari et al., 2008a; Brailov et al.,
2000; Ha¨ndel et al., 1999). These ciliary GPCRs exhibit remark-
ably specific and selective targeting to the ciliary membrane
compartment and are likely to facilitate cilium-dependent
signaling upon ligand binding. In mouse models of BBS, whichhors
recapitulate hallmarks of human disease (retinal degeneration,
obesity, sterility), ciliary GPCRs MCHR1 and SSTR3 fail to
localize to neuronal primary cilia (Berbari et al., 2008a, 2008b).
On the molecular level, a complex of proteins mutated in
Bardet-Biedl syndrome, the BBSome, has been shown to be
required for trafficking of at least some GPCRs, including
SSTR3 and MCHR1, to neuronal cilia (Berbari et al., 2008b; Jin
et al., 2010; Nachury et al., 2007); how directly the BBSome
connects ciliary GPCRs to the BBS-specific steps in GPCR traf-
ficking is an area of current investigation. In a recently discov-
ered mechanism, members of the Tubby family of proteins,
including TUB and Tubby-like protein 3 (TULP3), can recruit
the IFT-A intraflagellar transport complex to the ciliary mem-
brane, which is also required for trafficking of SSTR3 and
MCHR1 to the cilium (Mukhopadhyay and Jackson, 2011;
Mukhopadhyay et al., 2010; Sun et al., 2012). tubby mutant
mice display phenotypes partially resembling BBS, featuring
retinal degeneration and profound obesity (Kleyn et al., 1996).
These models of monogenic obesity syndromes underscore
the importance of GPCR trafficking to the neuronal cilia for regu-
lation of energy homeostasis. Strong supporting data come from
genetically engineered mice lacking adenylate cyclase type III
(ACIII), the single well-characterized downstream effector of
ciliary GPCR signaling; ACIII is highly enriched in neuronal cilia
in the hypothalamus and throughout the brain. The ACIII
knockout mice develop obesity at ages similar to BBS and tubby
mice (Davenport et al., 2007; Wang et al., 2009). The conser-
vation of BBS phenotype in mouse models also suggests that
the key GPCRs will have conserved ligand binding and targeting
sequences and signaling roles in mice and in humans.
The catalog of neuronal ciliary GPCRs has expanded with the
recent addition of dopamine receptors D1, D2, and D5 and the
orphan receptor GPR161, a regulator of Sonic Hedgehog
signaling; however, our understanding of how subcellular
GPCR distribution contributes to neuronal signaling function
remains unknown (Domire et al., 2011; Marley and von Zastrow,
2010; Mukhopadhyay et al., 2013). For example, systemic dele-
tion of SSTR3 leads to defects in long-term potentiation and
synaptic plasticity in hippocampal neurons, but the dependency
of this phenotype on SSTR3 subcellular localization is not clear
(Einstein et al., 2010). The fact that signaling through neuronal
primary cilia in the ACN is mediated by a GPCR(s) may provide
a compelling explanation for the role of cilia in regulating energy
homeostasis. A ciliary GPCR MCHR1 has been shown to be
expressed in the hypothalamus and is important in regulation
of weight and food intake. However, if failure to traffic MCHR1
to cilia in BBS and tubby mice was important to limit obesity,
MCHR1 loss of function should mirror BBS and tubby pheno-
types. In contrast, MCHR1 knockout mice are lean, and
MCHR1 inactivation decreases food intake, suggesting this is
not the mechanism driving obesity in these mouse models (Bor-
owsky et al., 2002; Ludwig et al., 2001; Shimada et al., 1998).
We sought to illuminate the role of neuronal primary cilium
in the hypothalamus by identifying ciliary GPCRs linked to
the BBS and tubby pathways and by validating their cilia-depen-
dent signaling in vitro and in vivo. Here, we identify neuropeptide
Y receptor NPY2R, among seven ciliary GPCRs we discovered,
as a candidate anorexigenic GPCR defective in hypothalamicCell Reneuronal ciliary signaling in BBS and tubby mice. Consistently,
we find BBS mice fail to respond to the anorexigenic action of
NPY2R’s endogenous ligand, neuropeptide PYY3-36. Further-
more, we show that the primary cilium enhances ligand-
dependent NPY2R signaling by live imaging of cAMP in an
engineered cell line. Together, our results suggest that the loss
of signaling via the anorexigenic NPY2R receptor and its cognate
ligand PYY3-36 is a potentially important determinant of the
obesity phenotype linked to Bardet-Biedl syndrome and other
monogenic obesity syndromes.
RESULTS
Identification of Ciliary GPCRs
Our approach to identification and validation of novel hypo-
thalamic ciliary GPCRs is presented in Figure 1A. We began by
selecting candidate GPCRs based on three criteria: (1) a
sequence homology search for known ciliary targeting se-
quences (CTS) gleaned from signals in SSTR3, Smoothened,
and rhodopsin (Table S1; Experimental Procedures), (2) high
expression of orphan GPCRs in the hypothalamus based on
in situ expression data available from the Allen Mouse Brain
Atlas, and (3) published evidence of physiological function in
energy homeostasis (Table S2). A GPCR selected for ciliary
localization assay may belong to more than one category. For
example, NPY2R is both highly expressed in the hypothalamus
and involved in energy homeostasis. We next constructed
C-terminal GFP fusions of the candidate receptors and tested
them for localization to primary cilia in retinal pigmented epithe-
lial (RPE) cells by immunofluorescence microscopy. RPE cells
are a commonly used model cell line for ciliation in neural cells,
and defects from ciliopathy patients (BBS, Joubert and
Meckel-Gruber syndromes) show distinctive loss of function
phenotypes in this cell model. After an initial set of localization
experiments, we expanded the candidate list by adding GPCRs
with significant sequence homology to the identified ciliary
GPCR PGR15L (Table S2).
Seven candidate GPCRs from 42 screened localized to cilia in
both fixed and live RPE cells; other candidates failed to localize
to cilia (Table S2). Specifically, we found that PGR15L, the NPY
family receptors 2 and 5 (NPY2R and NPY5R), the orphan recep-
tor GPR83, the galanin receptors 2 and 3 (GAL2R and GAL3R),
and the pyroglutamylated RFamide peptide receptor (QRFPR)
each distinctively localized to cilia (Figure 1B).With the exception
of PGR15L, which appears to be rodent specific, each of these
receptors is conserved in vertebrates, potentially revealing
ancient connections between primary cilia in the brain and
energy homeostasis.
Interestingly, GPR83 has been suggested to belong to NPY
receptor family based on the sequence homology and ligand
binding data (Sah et al., 2007). The NPY family of neuropeptides
consists of three related neuropeptides NPY, peptide YY (PYY),
and pancreatic polypeptide (PP), which bind and activate five
cognate GPCRs NPY1R, NPY2R, NPY4R, and NPY5R (NPY6R
is also found in mice) with varying affinity. NPY is predominantly
expressed in the brain, specifically in regions including the hypo-
thalamus, cerebral cortex, brain stem, striatum, and limbic struc-
tures, with the highest expression in the NPY neurons residing inports 5, 1316–1329, December 12, 2013 ª2013 The Authors 1317
Figure 1. Candidate GPCRs Regulating Energy Homeostasis Localize to Primary Cilia in Transfected RPE Cells and Cultured Primary
Hypothalamic Neurons
(A) Flowchart of strategies used to identify GPCRs regulating energy homeostasis and localized to neuronal primary cilia. See also Tables S1 and S2.
(legend continued on next page)
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the ACN (Lin et al., 2004; Nguyen et al., 2011). Unlike NPY, PYY
and PP are produced in the gut and released into general circu-
lation in direct proportion to ingested calories; PYY can then
target directly to the brain via transport across the median
eminence. Similarly to the ligands, NPY receptors show varying
distribution across central and peripheral tissues. The NPY1R re-
ceptors have the widest distribution in the brain with particularly
high expression in the paraventricular nucleus (PVN) of the hypo-
thalamus. The NPY5R is the most similar to NPY1R and is coex-
pressed with NPY1R in a smaller subset of brain regions. Among
all NPY receptors, NPY2R is the most highly expressed receptor
in the ACN (Fetissov et al., 2004). The NPY system has a well-
established role in balancing positive and negative signals for hy-
pothalamic regulation of energy balance (Nguyen et al., 2011).
Next, we confirmed specific enrichment of endogenous
GPCRs in cilia of cultured hypothalamic neurons using commer-
cially available and newly developed antibodies. We validated
that endogenous NPY2R, NPY5R, QRFPR, and GALR3 exclu-
sively localized to the primary cilia of embryonic rat hypothalamic
neurons (Figure 1C); these neurons were cultured to functional
maturity as judged by NPY expression. We were unable to
generate working antibodies against GALR2 and were thus
unable to validate its endogenous ciliary localization. GPR83
was not expressed in our neuronal preparations. Interestingly,
NPY5R staining revealed a range of localization patterns, from
exclusively ciliary to highly enriched in neuronal projections
(Figure S1A).
In wild-type (WT)mouse brain sections, we detected abundant
ciliary GPCR staining that colocalized with the ciliary marker
ACIII in brain regions expected to have high expression of the
mRNA encoding that receptor (Figure 2A). The QRFPR and
GALR3 proteins localized to neuronal cilia in the ventro- and
dorsomedial hypothalamus, respectively. GPR83-positive cilia
were highly prevalent in the olfactory tubercle, nucleus accum-
bens, caudate nucleus, and mammillary bodies. Consistently
with the staining observed in cultured hypothalamic neurons,
NPY5R staining was mainly observed in neuronal projections
and only weakly in neuronal cilia in the hypothalamus (Figures
2A, S1B, and S1C). Most strikingly, we observed NPY2R-posi-
tive cilia projecting from neurons in the ACN immediately adja-
cent to the third ventricle (3V) and median eminence, a structure
with a semipermeable blood-brain barrier (Figure 2A). The two
endogenous forms of PYY full-length PYY1-36 and processed
PYY3-36 are preferred ligands for NPY2R. PYY is released into
circulation by enterochromaffin (L) cells of the pancreas, small in-
testine, and colon following a meal and penetrates the ACN via
the median eminence to suppress appetite and food intake (Bat-
terham et al., 2003, 2002). NPY2R is expressed in 80% of NPY
neurons, as well as in POMC neurons in ACN, and acts to inhibit
signaling in these neurons, resulting in a net decrease in expres-
sion of orexigenic NPY and an increase in anorexigenic POMC
(Acuna-Goycolea and van den Pol, 2005; Batterham et al.,(B) Candidate ciliary GPCRswere transiently expressed asGFP fusions in RPE cel
primary cilia and pericentrin (Pcnt) to mark basal bodies.
(C) Cultured primary embryonic rat hypothalamic neurons (DIV13) stained with
marker ACIII, and neuropeptide Y (Npy). Example of Npy5r localization to neuron
10 mm. White arrows mark primary cilia enlarged in insets. Hoechst dye was use
Cell Re2002; Broberger et al., 1997; Challis et al., 2003). Indeed, we
observed NPY2R-positive cilia on NPY- and POMC-positive
neurons in culture and in the brain (Figures 1C, 2B, and 2C).
Our observations are consistent with a previous report showing
strong accumulation of NPY2R in ‘‘possible cilia’’ in ACN
neurons in intact mouse brains, whereas NPY2R staining in other
brain areas could only be revealed by prolonged treatment with
a microtubule-directed inhibitor of transport to neuronal pro-
cesses (Stanic et al., 2006). Thus, from our initial list of 42
potential ciliary GPCRs regulating energy homeostasis, we iden-
tified NPY2R as a likely candidate contributing to cilia-depen-
dent GPCR signaling in ACN neurons.
Requirements for Ciliary GPCRs Localization
Our screen revealed that the presence of the currently described
ciliary targeting sequence (CTS) does not reliably predict traf-
ficking to the cilia, suggesting that new targeting motifs exist
within GPCR sequences. Notably, PGR15L was the only ciliary
GPCR identified from the homology-based arm of the screen
(Table S1). To investigate the requirements for trafficking of
NPY2R to primary cilium in RPE cells, we used domain swapping
between the ciliary NPY2R and the closely related nonciliary
NPY1R (Table S2). We narrowed the region important to
NPY2R ciliary localization to the intracellular loops in the IC3-
IC4 region (Figure S2). The previously characterized Ax[A/S]
xxQ CTS within intracellular loop 3 (IC3) of SSTR3 is not present
in either NPY2R or the closely related GPR83 (Figure 3A) (Berbari
et al., 2008a). Instead, we determined that the [R/K][I/L]W
sequence in IC3 is required for ciliary localization by mutating
amino acid residues that were similar among Pgr15l, GPR83,
and NPY2R but dissimilar in nonciliary NPY1R (Figures 3A, 3B,
and S3). Engineering the RLWL amino acid sequence into
NPY1R (NPY1R mut1: RLK239R240 to RLW239L240) is sufficient
to target it to primary cilia (Figure 3B). Similar experiments with
the mut2 sequence were not successful, suggesting that mut2
sequence is not sufficient to drive ciliary trafficking of the noncili-
ary receptor. The RLWL sequence is present in each IC3 of our
identified ciliary GPCRs as well as some closely related noncili-
ary GPCRs, suggesting that additional sequence determinants
are important for selective targeting to primary cilia. Indeed,
swapping the IC4 of NPY2R into NPY1R (NPY1R [2R IC4])
is also sufficient for inducing robust targeting of nonciliary
NPY1R to the cilia (Figure 3B and S2). Similar results were ob-
tained for GPR83, suggesting that various NPY family receptors
share common determinants for ciliary trafficking (Figure S3).
The trafficking of GPCRs to cilia and presumably their ability to
effectively signal is not only determined by sequence determi-
nants within GPCRs but also by trans-acting factors, including
BBS proteins and Tubby family proteins (Berbari et al., 2008b;
Jin et al., 2010). Both the BBSome and Tubby/TULP3 proteins
contain domains that bind to the ciliary membrane and separate
domains that couple to proteins within the primary cilium.ls. Cells were fixed and immunostained for acetylated a-tubulin (Ac-tub) tomark
antibodies against indicated candidate ciliary GPCRs, neuronal primary cilia
al projections as well as cilia is presented in Figure S1A. Scale bars represent
d to label nuclei (DNA) in this and all other figures.
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Figure 2. GPCRs Controlling Energy Homeostasis, Including the Neuropeptide Y Family Receptor NPY2R, Localize to Neuronal Cilia In Vivo
(A) Coronal brain sections WT mouse stained with antibodies for indicated GPCRs and ACIII. ME, median eminence; ACN, arcuate nucleus; OT, olfactory
tubercle; DMH and VMH, dorso- and ventromedial hypothalamus. Chanel-separated images of NPY5R staining in ACN is presented in Figures S1B and S1C.
(B and C) ACN section stained for NPY2R, ACIII, prepro NPY (ppNPY), and POMC, respectively. Scale bars represent 10 mm, unless otherwise indicated. White
arrows mark primary cilia enlarged in insets.Although the detailed mechanisms remain unclear, both path-
ways are required for localization of specific GPCRs to cilia
(Berbari et al., 2008b; Jin et al., 2010; Mukhopadhyay et al.,
2010; Sun et al., 2012). Despite lacking a typical SSTR3 IC3
CTS, which has been proposed to directly bind to the BBSome,
localization of NPY2R to cilia was decreased following depletion
of BBSome subunit BBIP10 (Figure 3C). We previously dis-
covered BBIP10 (BBIP1) as an obligatory component of the
BBSome required for its stability (Loktev et al., 2008). In a recent
study, Scheidecker et al. (2013) identified a homozygous
nonsense mutation (Leu58*) in a BBS patient, making it the
18th gene (BBS18) to be causally linked to BBS disease. Deple-
tion of the IFT-A regulator TULP3 in the same assay results in a
similar failure of NPY2R to traffic to the primary cilium (Figure 3C).
Interestingly, depletion of BBS3, which is not a BBSome subunit,
did not prevent NPY2R trafficking to the cilia (Figure 3C). Thus,1320 Cell Reports 5, 1316–1329, December 12, 2013 ª2013 The AutNPY2R possesses a CTS that drives its trafficking to the ciliary
membrane via a BBS and TULP3-dependent pathways.
Hypothalamic Neuronal Cilia Lack NPY2R in Bbip10/
and Tubby Mice
Genetically engineered mouse models of BBS faithfully recapit-
ulate the majority of human symptoms, including obesity (Norris
and Grimes, 2012). Because we believe that a number of ciliary
GPCRs and other factors may contribute quantitatively to weight
gain and feeding control, we focused on a specific misregulation
of NPY2R signaling in monogenic obesity models. Based on our
in vitro data, we hypothesized that failure to traffic NPY2R to cilia
of ACN neurons would result in defective PYY signaling in vivo.
To test this hypothesis, we generated knockout mice lacking
the BBIP10 (BBIP1, BBS18) BBSome subunit, which is required
for NPY2R ciliary localization in vitro (Figures 3C and S4) (Loktevhors
et al., 2008). Bbip10/ mice bred on a pure C57/BL6J genetic
background did not survive until weaning. Careful observations
revealed that knockout pups were born live at Mendelian ratios
but died within 24–36 hr after birth. Histological examination of
newborn knockout mice did not reveal any gross pathological
abnormalities to suggest the cause of death. To improve survival
to adulthood, we crossed C57/BL6J Bbip10/ mice with 129/
SvJ inbred WT animals. The mixed genetic background
increased the number of knockout mice surviving until weaning
to approximately 40% of the expected Mendelian ratio. Given
the previously described role for BBIP10 in tubulin acetylation
and physical interaction between the BBSome and K40 tubulin
acetyl transferase, we examined ciliation and tubulin acetylation
in Bbip10/ mouse embryonic fibroblasts (Loktev et al., 2008;
Shida et al., 2010). We found that levels of ciliation and K40
tubulin acetylation were indistinguishable between WT and
knockout MEFs (Figures S5A–S5C). Tubulin acetylation was
also unperturbed in the brains of the adult knockout mice (Fig-
ure 5F). We suspect that the knockout mouse has adequate
time to adapt and establish tubulin acetylation, whereas tran-
sient depletion in cultured cells causes a more dramatic effect.
Our interpretation is that BBIP10 is more important for the regu-
lation of tubulin acetylation, rather than a core determinant of
tubulin acetyltransferase activity.
Broadly, Bbip10/ mice show defects similar to all other
published Bbs knockout mice, including obesity, hyperphagia,
retinal degeneration, andmale sterility (Figures 4A–4C; Figure S6)
(Norris and Grimes, 2012). We observed defective ciliary
SSTR3 localization in Bbip10 knockout mice similar to
previously published Bbs2 and Bbs4 knockout animals (Fig-
ure S5D). Similar to Bbs3/, but unlike Bbs2/ and Bbs4/
mice, Bbip10/mice display normal ciliary MCHR1 localization
(Figure S5E) (Berbari et al., 2008b; Zhang et al., 2011). Consis-
tently with the published report, we observed defective SSTR3
and MCHR1 localization in tubby mice (Figures S5D and S5E)
(Sun et al., 2012).
Staining brain sections of the hypothalamus from young
Bbip10/ mice revealed a lack of NPY2R in ACN cilia, whereas
the levels of Npy2r mRNA and protein expression in the hypo-
thalamus were unchanged (Figures 4D, 5E, and 5F). Similar
results were obtained in Bbs2/ and Bbs4/ mouse brains
(data not shown). Importantly, NPY2R was also absent from cilia
of both young and older obese tubby mice (Figure 4D). Lack of
ciliary NPY2R in Bbip10/ and tubbymice suggests a possible
unifying molecular explanation for the obesity observed in these
previously unrelated monogenetic obesity models.
Bbip10/ Mice Fail to Respond to Anorexigenic
PYY3-36
Peripheral administration of PYY3-36 was shown to inhibit appe-
tite and food intake in humans and in WT, but not in Npy2r/
mice (Batterham et al., 2003, 2002). We hypothesized ciliary
localization of NPY2R to be important for ligand-dependent
signaling in vivo, and we predicted that Bbip10/ mice would
fail to respond to PYY. Indeed, in a starvation-refeeding experi-
ment, whereas WT mice strongly suppressed food intake after
PYY3-36 injection, we observed no change in food intake in
Bbip10/ mice (Figure 5A). Consistently, compared to controlCell Remice, Bbip10/ mice showed neither PYY3-36-induced
upregulation of the anorexigenic POMC mRNA in the hypo-
thalamus nor induced neuronal activation in the ACN detected
as judged by staining for c-fos, a marker of long-term neuronal
activity (Figures 5B–5D) (Batterham et al., 2002). In some cases,
the failure of a peptide hormone to achieve its downstream reg-
ulatory effect can induce a compensatory upregulation of the
hormone, in many cases because of loss of feedback for the hor-
mone linked to a failure of pathway activation. Hyperaccumula-
tion of peptide hormone may thus suggest a loss of systemic
response to the hormone signaling. Consistent with this model,
we observed strongly elevated levels of circulating serum PYY
in Bbip10/ mice compared to controls (446 ± 54 pg/ml versus
213 ± 59 pg/ml, mean ± SEM, p < 0.01, n = 6), potentially sug-
gesting the development of PYY resistance and a compensatory
upregulation of PYY secretion in knockout mice. Similarly to
Bbip10/ mice, either hypothalamus-specific deletion of
Npy2r or systemic loss of PYY leads to increased food intake,
body weight, and adiposity (Batterham et al., 2006; Shi et al.,
2010). Importantly, obese humans and diet-induced obese ro-
dent models remain responsive to anorexigenic action of
PYY3-36, suggesting that the lack of response in Bbip10/
mice is due to a defect in NPY2R receptor signaling rather than
a secondary effect of obesity (Batterham et al., 2003; Pittner
et al., 2004).
Ciliary Localization Is Essential for NPY2R Signaling in
Cells
We next asked if localization of NPY2R to cilia is important for
ligand-dependent signaling. First, we looked for evidence of
homologous desensitization by PYY3-36. In many GPCR sys-
tems, internalization of the receptor by endocytosis is the result
of productive ligand-receptor signaling interactions. Indeed,
plasma membrane localized NPY2R has been shown to inter-
nalize following PYY3-36 binding (Bo¨hme et al., 2008), which
correlates with receptor activation. For ciliary NPY2R, is internal-
ization and receptor depletion from cilia triggered by ligand?
Strikingly, we observed a decreased percentage of NPY2R-pos-
itive cilia in PYY3-36-treated cultured neurons. This desensitiza-
tion effect was blocked by concurrent treatment with the
NPY2R-specific antagonist BIIE0246 (Figure 6). Intriguingly,
because we find that the state of ciliary signaling through
NPY2R and other ciliary receptors may be influenced by ligand
binding, a reasonable inference is that receptor localization
may report on signaling status in obese patients or more broadly
in patients with other diseases linked to ciliary signaling.
To determine if the presence of primary cilia augments NPY2R
signaling in cells, we developed a live-cell cAMP imaging assay.
RPE cells stably expressing mCherry-tagged NPY2R and a
cAMP fluorescence resonance energy transfer (FRET)-based
sensor TEpacVV allowed us to record changes in cAMP levels
after ligand stimulation in live cells with or without a cilium (Klar-
enbeek et al., 2011). The NPY family receptors are coupled to
pertussis toxin-sensitive inhibitory G proteins (G0/Gi) that inhibit
adenylate cyclase and consequently block cAMP accumulation
upon activation (Figure 7A). As with most canonical G0/Gi-
coupled GPCR, no changes were observed upon perfusion
with PYY3-36 alone (Figures 7B and S7; Movie S1). Briefports 5, 1316–1329, December 12, 2013 ª2013 The Authors 1321
Figure 3. The NPY2R Receptor Harbors Ciliary Targeting Sequences
(A) Sequence alignment of IC3s of Pgr15l, NPY2R, and GPR83 compared to closely related nonciliary GPCR NPY1R. Boxed amino acids in bold were mutated in
NPY2R (mut1 and mut2) and tested for ciliary targeting. NPY1R mut1 and mut2 were tested for gain of ciliary targeting.
(legend continued on next page)
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Figure 4. NPY2R Is Missing from Neuronal Primary Cilia in BBS-Defective Mice
(A) Bbip10/ mice (generated as shown in Figure S4) develop obesity and hyperphagia similar to other BBS mouse models. Photograph of a representative
female mice at 12 weeks of age.
(B) Body weight changes of female Bbip10/ mice over time (n = 6–8).
(C) Mean daily food intake of 5-month-old female Bbip10/ mice (n = 8).
(D) Coronal sections of ACN from 6- to 8-week-old Bbip10/ and Tubby mice stained for NPY2R and ACIII, showing decrease in NPY2R ciliary localization in
mutant mice (n = 4). Error bars represent ± SEM. Scale bars represent 20 mm. *p < 0.05. **p < 0.01.treatment with a low concentration of the nonspecific AC acti-
vator forskolin produced a reversible increase in cAMP
(decrease in FRET). This increase was significantly diminished
when cells expressing NPY2R were treated with PYY3-36 pre-
ceding perfusion (Figures 7C and S7; Movie S2). Among
NPY2R-expressing cells, those with primary cilia produced
more pronounced cAMP inhibition following addition of ligand.
We confirmed the specificity of NPY2R signaling in the assay
by treatment with antagonist BIIE0246 applied before PYY3-36(B) RPE cells were transfected with WT or mutated NPY2R and NPY1R GFP-fusio
panel shows ciliary targeting of chimeric NPY1R harboring IC4 from NPY2R (see
shown for each mutant. The effect of CTS mutagenesis of the closely related GP
(C) RPE cell line stably expressing NPY2R-GFP was transfected with indicated s
GFP were calculated and plotted. Error bars represent ± SEM. ***p < 0.001 com
Cell Religand (Figure 7C); this inhibitor ablated the PYY3-36 effect.
Thus, our data support that the cilium positively contributes to
PYY signaling in this cultured cell system and suggests that
in vivo signaling may be dependent on the ciliary machinery.
DISCUSSION
Recent advances in primary cilia research highlight the impor-
tance of this organelle in signaling on the level of individual cellsn constructs (as in A) and immunostained for Ac-tub and Pcnt. The lower right
also Figure S2). Percentage of cilia in GFP-positive cells with ciliary GPCR is
R83 is presented in Figure S3. Scale bars represent 10 mm.
iRNAs. Percentage of ciliated cells and percentage of cilia positive for NPY2R-
pared to control (ANOVA) (n > 300, from three independent experiments).
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Figure 5. Localization of NPY2R to Neuronal Cilia Is Essential for the Anorexigenic Effect of the NPY2R Ligand PYY3-36
(A) Food intake over time in fasted Bbip10/ and Bbip10+/+mice following injection of PYY3-36 or saline (n = 6 for each group). Mice were tested at 8–9 weeks of
age before onset of obesity.
(B) Changes in relative levels of POMC mRNA in hypothalamus of Bbip10/ mice 2 hr after PYY3-36 injection (n = 3, per group).
(C and D) c-Fos staining of ACN coronal sections from fasted Bbip10/ and Bbip10+/+ mice (n = 3, per group) 2 hr after injection with PYY3-36 or saline.
(legend continued on next page)
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Figure 6. NPY2R Exits Primary Cilia in
Primary Embryonic Rat Hypothalamic
Neurons after Binding by Its Specific
Cognate Ligand PYY3-36
(A and B) Representative images of cultured pri-
mary rat hypothalamic neurons (DIV13) before (A)
and after (B), 120 min treatment with 100 nM
PYY3-36 stained with antibodies against NPY2R,
ACIII, and neuronal marker MAP2. Scale bars
represent 10 mm. Arrows mark primary cilia.
(C) Cultured neurons (DIV13) were treated as
indicated in the legend for 30, 60, and 90 min and
processed as in (A). The percentage of neurons
(MAP2 positive) displaying ciliary NPY2R is plotted
over time (n > 200 from three independent exper-
iments). Error barsrepresent ± SEM. **p < 0.01.as well as the whole organism. The organismic effect of ciliary
loss is illustrated by a number of human primary cilia disorders
collectively known as ciliopathies (Novarino et al., 2011). Obesity
in ciliopathies, such as BBS, has been connected with a
malfunction of central regulation of food intake and energy
expenditure. High leptin levels and leptin resistance in mouse
models of BBS suggest a potential connection between the
primary cilium and leptin signaling (Guo and Rahmouni, 2011).
Nevertheless, the leptin receptor does not appear to localize to(E) Npy2rmRNA expression in hypothalamus is not perturbed inBbip10 knockout animals. Relative levels of N
used in Figure 6B.
(F) Western blot analysis of brain lysates fromWT and Bbip10/mice showing similar levels NPY2R protein a
Scale bars represent 20 mm. *p < 0.05. **p < 0.01.
Cell Reports 5, 1316–1329, Dethe cilia (A.V.L. and P.K.J., unpublished
data), and it has not been clear whether
leptin resistance is a cause or a conse-
quence of increased fat mass in obese
BBS knockout animals (Seo et al.,
2009). A recent study utilizing preobese
ciliopathy mutant mice strongly supports
that hyperleptinemia and leptin resis-
tance are secondary consequences of
hyperphagia-driven obesity (Berbari
et al., 2013). Nonetheless, the proposed
mechanism of action for BBS proteins in
trafficking GPCRs to neuronal cilia pro-
vided an appealing explanation of the
nature of ciliary dysfunction in BBS.
Among seven ciliary GPCRs identified in
our screen, NPY2R best fits the criteria
for a GPCR that signals in cilia of neurons
in arcuate nucleus. These criteria include
localization to cilia in POMC- and NPY-
expressing neurons in ACN, overall
anorexigenic output from the receptor
signaling in response to the native ligand,
and mislocalization in BBS knockout
mice. We provide compelling evidence
that primary cilia on hypothalamic neu-
rons directly respond to peripheralhormonal stimulation by PYY3-36 through NPY2R, normally
resulting in the inhibition of food intake, but highly dependent
on the BBS and Tubby pathways for this ciliary signaling. Never-
theless, we cannot exclude that other factors besides NPY2R
mislocalization in cilia are driving hyperphagia and obesity in
BBS knockout or Tubby mice. Additional studies in conditional
knockout models will be needed to distinguish between central
and peripheral defects. It will be interesting to examine the role
of NPY2R ciliary localization in adipose tissue in light of itspy2rmRNAwere analyzed in the total RNA samples
nd tubulin acetylation. Error bars represent ± SEM.
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Figure 7. Primary Cilia Augment cAMP Inhibition upon Activation of
NPY2R Receptor by PYY3-36
(A)Diagramof theepac2cAMPFRET-basedassay.RPEcells stably expressing
TEpacVV cAMP sensor and NPY2R-mCherry (RPE-Epac-NPY2R) were used to
measure FRET, which is inversely proportional to cAMP concentration in cells.
(B) Normalized aggregated FRET measured in RPE-Epac-NPY2R cells during
perfusion with buffer, PYY3-36, or BIIE0246 followed by PYY3-36 and
compared among cells with or without primary cilia (± cilia) (Movie S1).
(C) Ciliated cells exhibit significantly augmented NPY2R-dependent inhibition
of cAMP signaling upon addition of PYY3-36 ligand in epac2 cAMP sensor
assay. RPE-Epac-NPY2Rwere perfused for 30 s with either PYY3-36 or PYY3-
36 and then NPY2R antagonist BIIE0246, followed by 30 s in forskolin. FRET
was measured during perfusion and compared between cells with or without
primary cilia (± cilia) (Movie S2). Examples of cell images are presented in
Figure S7. The number of cells measured in each treatment is indicated in the
legend (n). Error bars represent ± SEM. **p < 0.01.
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response (Kuo et al., 2007). Interestingly,Bbs3 knockout animals
exhibit the key characteristics of the Bardet-Biedl syndrome,
except that they do not show overt obesity and hyperphagia
(Zhang et al., 2011). Moreover, these Bbs3 animals do not
have defects in MCHR1 localization to neuronal cilia, empha-
sizing the link between ciliary localization in neurons and regula-
tion of feeding control. These data and the fact that trafficking of
NPY2R to the cilia is not perturbed after BBS3 knockdown (Fig-
ure 3C) support our hypothesis that NPY2R is a major driver of
hyperphagia-induced obesity in BBS. We suggest that in BBS3
mice and patients, another aspect of ciliary signaling, separate
from GPCR trafficking, would be defective.
Our study further illustrates that the inventory of ciliary GPCRs
is not complete. A search using identified CTS or a localization
screen using the entire repertoire of GPCRs will undoubtedly
yield another subset of receptors targeted to the cilia. It is inter-
esting to consider whether GPCRs within one receptor family
and recognizing the same or similar ligands (NPY receptors,
dopamine receptors) evolved to be compartmentalized within
the cilia or began as ciliary and evolved to other nonciliary roles.
Given the high degree of conservation of ciliary trafficking path-
ways, early ciliary GPCRs in single-cell organisms could have
diversified during the evolution of multicellularity and tissue
specialization. Primordial receptors could have duplicated and
diverged to evolve mechanisms for balanced positive and nega-
tive signals and thus provide more robust signaling control. Vari-
ability of NPY5R localization highlighted in our study suggests
that it is possibly regulated by a signaling state in the short
term or neuronal identity in the long term. Does subcellular local-
ization of a neuronal GPCR alter its ligand recognition profile?
In summary, we demonstrate that trafficking of specific
subsets of GPCRs to neuronal cilia, exemplified in this study
by neuropeptide Y receptors, is essential for effective physiolog-
ical neuronal signaling by their respective ligands.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents
NPY2R antibodies were obtained from Neuromics (RA14112). They were
previously validated on Npy2r knockout mouse tissue (Stanic et al., 2006).
NPY5R, GALR3, and QRFPR antibodies were raised in rabbits against
synthetic peptides conjugated to KHL andwere affinity purified using standard
protocols. Synthetic peptides used for immunizations were as follows: NPY5R
amino acid residues 265–289, GALR3 amino acid residues 304–359, and
QRFPR amino acid residues 406–424. Commercial antibodies used were
against acetylated a-tubulin (mAb 6-11B-1, Sigma), rabbit pericentrin
(ab4448, Novus), GFP (3E6, Invitrogen), GPR83 (Genetex, 108229), ACIII
(Santa Cruz Biotechnology, sc-588), NPY (Millipore, AB1583), MCHR1 (Santa
Cruz Biotechnology, sc-5534), SSTR3 (sc-11617), and c-fos (Cell Signaling,
9F6). All secondary antibodies were from Jackson Immunoresearch and
included Dylight 488-, 594- and 649-conjugated donkey anti-species anti-
bodies. For primary cilia staining in the brain, ACIII antibodies directly labeled
with DyLight Fluor 488 or 594 labeling kits (Pierce) were used. All peptides and
reagents were from Sigma-Aldrich unless otherwise noted. BIIE0246 was from
Tocris Bioscience.
Bioinformatics Approach for Identifying Ciliary GPCRs
Identification of GPCRswith AX[S/A]XQCTS in their ic3 was carried out essen-
tially as previously described by Berbari et al. (2008a), with the following
modifications. We added all annotated mouse GPCRs to the searchedhors
database of all human GPCRs. Additional search criteria included Smooth-
ened (Smo) ciliary targeting sequence [FWY][KR] located within ic4 and C-ter-
minal Opsin sequence VXPX.
Plasmids
cDNAs for GPCRs were obtained from vendors indicated in Table S1. GPCR-
GFP fusion expression constructs were generated byGateway subcloning into
pG-LAP5 vector (Torres et al., 2009). The TEpacVV plasmid was a gift from Dr.
K. Jalink (Klarenbeek et al., 2011). NPY2R-mCherry was constructed by
Gateway subcloning into in-house-generated pBABE/mCherry-C/Puro vector.
Cell Culture and Transfections
Plasmids were transfected into RPE-hTERT cells using Fugene 6 (Roche) in
accordance with the manufacturer’s instructions. Cells were shifted from
10% serum to 0.2% serum 24 hr after transfection to induce ciliation and
were fixed 48 to 72 hr posttransfection. GPCR-GFP stable cell lines were
generated using an in-house-generated RPE Flp-In cell line following the
general Flp-In guidelines (Invitrogen). An On-Target Plus small interfering
RNA (siRNA) control from Dharmacon was used as control siRNA. Targeting
siRNAs and transfection method were previously described (Loktev et al.,
2008; Mukhopadhyay et al., 2010).
For primary rat embryonic hypothalamic neuronal culture, day E18 embryos
from timed pregnant Sprague Dawley rats (Charles River) were obtained and
hypothalami dissected from brains. Tissue was dissociated using Papain
Dissociation System (LK003153, Worthington) in accordance with the manu-
facturer’s instructions. Cells were plated on mouse laminin/poly-D-lysine-
coated glass covers slips in Neurobasal-A media supplemented with 5%
B27, 1% GlutaMax, and 1% Pen/Strep (Invitrogen) at density 70,000 cells/
cm2. Neurons were allowed to differentiate for 14 days with 50% media
changes every 3 days before use for experiments. For drug addition experi-
ments, drugs were diluted to 23 final concentration in media, and equal vol-
ume of media was slowly added to the wells after 50% of the media was
removed.
Mice
All mice were maintained under specific pathogen-free conditions at the
Genentech animal care facility. All the experiments involving animal usage
were approved by the Institutional Animal Care and Use Committee at Genen-
tech. All procedures were performed in accordance with the institutional
guidelines as stated in the Animal Welfare Act and The Guide for the Care
and Use of Laboratory Animals. Tubby mice B6(Cg)-Tubtub/J were obtained
from the Jackson Laboratory (stock number 000562) and were maintained
by crossing to C57BL6 mice (Coleman and Eicher, 1990; Kleyn et al., 1996).
The construct for targeting the C57BL/6 Bbip10 locus in ES cells was made
using a combination of recombineering (Liu et al., 2003; Warming et al., 2006)
and standard molecular cloning techniques. Briefly, a 4,917 bp fragment (as-
sembly NCBI37/mm9, chr19: 47116098-47121015) from a C57BL/6 mouse
BAC was first retrieved into plasmid pBlight-TK (Warming et al., 2006). Sec-
ond, a loxP-em7-neo-loxP cassette was inserted upstream of exon 2 (position
chr19: 47118238). Correctly targeted plasmidwas transformed into arabinose-
induced SW106 cells (Cre-expressing Escherichia coli) to remove kanamycin
and leave behind a single loxP site. Finally, a frt-PGK-em7-Neo-BGHpA-frt-
loxP cassette was inserted downstream of exon 2 (position chr19:
47118177), resulting in the knockout (KO) targeting vector. The final vector
was confirmed by DNA sequencing. The Bbip10 KO vector was linearized
with NotI, and C57BL/6 C2 ES cells were targeted using standard methods
(G418-positive and gancyclovir-negative selection). Positive cloneswere iden-
tified using PCR and Taqman analysis and confirmed by sequencing of the
modified locus. For the purposes of this study, correctly targeted ES cells
were transfected with Cre plasmid to create the Bbip10 KO allele. Bbip10
KO ES cells were injected into blastocysts using standard techniques, and
germline transmission was obtained after crossing resulting chimeras with
C57BL/6N females. Primer for PCR genotyping included F1: 50-AGGCG-
GATTTCTGAGTTCG, F2: 50-ACAATGTGAAACTGTCAAGT, and R1: 50-
CTTCTGTTGCCATATGACGT. Two independent founders were used to
establish breeding colonies and confirm knockout phenotype. Bbip10/
mice on pure C57/BL6J genetic background did not survive until weaning.Cell ReTo improve the survival to adulthood of Bbip10/ mice, we bred them with
129/SvJ inbred animals. Mixed genetic background increased the number of
knockout mice surviving until weaning to 40% of the expected Mendelian
ratio.
Thus, the experimental cohorts were generated by first breeding Bbip10/+/
BL6 and 129/SvJ mice (Charles River) to produce Bbip10 /+/BL6/129 mixed
background mice. The F1 Bbip10 /+/BL6/129 were intercrossed to produce
Bbip10 +/+ Bbip10 /+ Bbip10 / littermates.
Mice were housed at 22C –24C in a 14/10 hr light-dark cycle with free
access to water and standard mouse chow (Laboratory Autoclavable Rodent
Diet 5010 [LabDiet], 4.14 kcal/g gross energy, 3.08 kcal/g metabolizable
energy). Body weight was measured weekly starting from the second week
of age. Mice were housed 4 to 5 per cage, except for selected mice occasion-
ally kept individually for food intake measurement. In these experiments, food
pellets and spilled food on the cage floor were weighed daily for 5 days and
averaged for each mouse.
Food intakemeasurements after PYY3-36 injections were performed essen-
tially as described (Parkinson et al., 2008). Briefly, 8 to 9-week-old Bbip10/
and Bbip10 +/+ were acclimated to individual housing and daily handing for
7 days followed by 3-day acclimation to daily intraperitoneal (i.p.) saline injec-
tions. Next, mice were fasted for 24 hr starting at 9 a.m. At 9 a.m. the following
day, mice were injected with either PYY3-36 (23 nmol/kg in sterile saline) or
saline and were given free access to food. Food weight was measured at 1,
2, 4, and 6 hr postinjections. For tissue harvest and staining separate cohorts
of mice were handled as described above, except at 2 hr after PYY3-36 injec-
tion mice were sacrificed and tissues harvested.
Tissue Preparation and Quantitative Real-Time PCR
Mice were sacrificed by carbon dioxide inhalation, and brains were rapidly
removed. A block of tissue encompassing the hypothalamus was immediately
dissected from the brains and placed in an Eppendorf tube in liquid nitrogen.
The isolated hypothalami were stored at 70C until RNA extraction. Total
RNA was extracted from the hypothalami using RNeasy Lipid Tissue Kit
(QIAGEN). cDNA was synthesized using SuperScript III (Invitrogen) and used
for quantitative real-time PCR with TaqMan Gene Expression kit (ABI).
All Taqman probes were from ABI Agrp (Mm00475829_g1), Npy
(Mm03048253_m1), Pomc (Mm00435874_m1) Npy2r (Mm00435350_m1),
Bbip10 (Mm01261161_m1), and endogenous normalizer Rpl19
(Mm02601633_g1).
For brain immunohistochemistry, mice were deeply anesthetized by a 0.1ml
per 10 g of body weight i.p. injection of ketamine/xylazine, sacrificed by
cardiac puncture, and transcardially perfused with PBS followed by 4%
paraformaldehyde in PBS. Brains were removed and further fixed in 4% para-
formaldehyde in PBS for 16–24 hr at 4C followed by cryoprotection in 30%
sucrose in PBS for 16–24 hr. For immunofluorescence procedures, cryopro-
tected brains were embedded in OCT compound (Tissue-Tek) and sectioned
in a cryostat at a thickness of 8 mm.
Immunofluorescence and Microscopy
For immunofluorescence experiments, cells were grown on glass coverslips
and fixed in 4% paraformaldehyde in PBS for 10 min at room temperature.
Cells were blocked/permeablized with immunofluorescence (IF) buffer (3%
BSA, 0.1% NP40 in PBS) supplemented with 10% normal donkey serum for
1 hr at room temperature and incubated with primary antibody in IF buffer
for 1 hr at room temperature. After washing and incubation with fluorescent
secondary antibodies, coverslips were stained with Hoechst dye andmounted
on slides. The immunofluorescence staining of brain sections was carried out
using similar protocol, except concentration of NP40 in IF buffer was 0.3% and
primary antibody incubation was 16–24 hr at 4C. In case of GPCR/ACIII
double labeling, brain sections were processed as described above followed
by incubation with fluorescently labeled rabbit ACIII antibody, final wash,
and coverslipping.
Images were acquired on an Everest deconvolution workstation (Intelligent
Imaging Innovations) equipped with a Zeiss AxioImager Z1 microscope and
a CoolSnapHQ cooled CCD camera (Roper Scientific). Ten to thirteen z-sec-
tions at 0.5 mm interval were acquired, and z stacks were deconvolved and
projected using Slidebook 5 software (Intelligent Imaging Innovation). For brainports 5, 1316–1329, December 12, 2013 ª2013 The Authors 1327
sections, a Zeiss 510 laser scanning confocal microscopewas used to capture
multiple consecutive focal planes. Contrasts were adjusted identically for each
series of panels.
Live-Cell cAMP Imaging
The RPE TEpacVV /NPY2R-mCherry cAMP sensor cell line was generated by
first introducing the TEpacVV plasmid into RPE cells by transfection and select-
ing stably expressing cells with G418. The resulting RPE TEpacVV cell line was
infected with pBABE/ NPY2R-mCherry/Puro retrovirus and selected with
puromycin. Cells grown on 15mmglass coverslips were placed on an inverted
Zeiss 200M microscope equipped with SmartSquirt Perfusion System
controlled by ValveLink8.2 controller (AutoMate Scientific) through SlideBook
5 software. All imaging was performed at room temperature (22C–23C) with
constant perfusion of buffer (144 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 2 mM
CaCl2, and 10mMHEPES [pH 7.3]) at a rate of0.5ml/min. Cells were excited
at 425 nm (CFP) or 589 nm (mCherry). Emission was detected using optical
filters as follows: (band-pass filters) CFP, 470 ± 20 nm; YFP, 530 ± 25 nm;
mCherry 632 ± 22 nm. Data from donor and acceptor were collected simulta-
neously every 15 s, and FRET was expressed as a ratio of donor-to-acceptor
signals. The FRET was normalized to 1.0 at the onset of the experiments. For-
skolin concentration was chosen to produce robust and reversible change of
cAMP levels following 30 s perfusion followed by 14 min washout. FRET
changes are expressed as a fraction of the initial value of 1.0.
Statistical Analysis
All values are displayed as mean ± SEM. Data were analyzed by unbalanced
two-way analysis of variance (ANOVA) for variables changing over time.
Comparisons between two groups were made by unpaired two-tailed Stu-
dent’s t test.
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